COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Abstract Coronavirus Disease‐19 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome‐coronaviruses‐2 (SARS‐CoV‐2), a highly pathogenic and transmissible coronavirus. Most cases of COVID‐19 have mild to moderate symptoms, including cough, fever, myalgias, and headache. On t...
Saved in:
Main Authors: | Ilker Polatoğlu, Tulay Oncu‐Oner, Irem Dalman, Senanur Ozdogan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | MedComm |
Subjects: | |
Online Access: | https://doi.org/10.1002/mco2.228 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
by: Fábio Mambelli, et al.
Published: (2025-01-01) -
Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China
by: Chao-Chao Qiu, et al.
Published: (2025-02-01) -
Cryptic transmission of a SARS-CoV-2 variant detected by wastewater surveillance in Panama
by: Melissa Gaitán, et al.
Published: (2025-01-01) -
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
by: Fabrizio Angius, et al.
Published: (2024-12-01) -
On the space of SARS-CoV-2 genetic sequence variants
by: A. Yu. Palyanov, et al.
Published: (2023-12-01)